Snowflake Score | |
---|---|
Valuation | 3/6 |
Future Growth | 1/6 |
Past Performance | 2/6 |
Financial Health | 6/6 |
Dividends | 3/6 |
BML, Inc. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | JP¥2,746.00 |
52 Week High | JP¥3,125.00 |
52 Week Low | JP¥2,592.00 |
Beta | 0.26 |
11 Month Change | 1.63% |
3 Month Change | 0.33% |
1 Year Change | -2.17% |
33 Year Change | -26.97% |
5 Year Change | -12.55% |
Change since IPO | 92.96% |
Recent News & Updates
Shareholder Returns
4694 | JP Healthcare | JP Market | |
---|---|---|---|
7D | -1.6% | -1.2% | 1.4% |
1Y | -2.2% | -2.7% | 15.3% |
Return vs Industry: 4694 matched the JP Healthcare industry which returned -2.7% over the past year.
Return vs Market: 4694 underperformed the JP Market which returned 15.3% over the past year.
Price Volatility
4694 volatility | |
---|---|
4694 Average Weekly Movement | 2.1% |
Healthcare Industry Average Movement | 3.9% |
Market Average Movement | 4.0% |
10% most volatile stocks in JP Market | 7.7% |
10% least volatile stocks in JP Market | 2.3% |
Stable Share Price: 4694 has not had significant price volatility in the past 3 months compared to the JP market.
Volatility Over Time: 4694's weekly volatility (2%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1955 | 4,513 | Kensuke Kondo | www.bml.co.jp |
BML, Inc. provides laboratory testing and related services in Japan. The company offers a range of laboratory testing, such as biochemical and hematologic examination; special laboratory test, including RIA, cellular, immunological, and DNA analysis; and microbiological tests for medical and pharmaceutical societies and organizations; laboratory tests in tumorology, infectious disease, diabetes, hypertension, allergy, and genetic studies, as well as develops Frontier and Symphony automation systems, which automate pre-processing procedures from sorting to dispensing, and subsequent test procedures. It also provides medical information system services, which include electronic medical charts for networking medical information, as well as preventive medicine services.
BML, Inc. Fundamentals Summary
4694 fundamental statistics | |
---|---|
Market cap | JP¥109.04b |
Earnings (TTM) | JP¥5.95b |
Revenue (TTM) | JP¥138.28b |
18.0x
P/E Ratio0.8x
P/S RatioIs 4694 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
4694 income statement (TTM) | |
---|---|
Revenue | JP¥138.28b |
Cost of Revenue | JP¥92.77b |
Gross Profit | JP¥45.52b |
Other Expenses | JP¥39.57b |
Earnings | JP¥5.95b |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
Feb 07, 2025
Earnings per share (EPS) | 152.50 |
Gross Margin | 32.92% |
Net Profit Margin | 4.30% |
Debt/Equity Ratio | 0% |
How did 4694 perform over the long term?
See historical performance and comparisonDividends
3.6%
Current Dividend Yield52%
Payout RatioDoes 4694 pay a reliable dividends?
See 4694 dividend history and benchmarksBML dividend dates | |
---|---|
Ex Dividend Date | Sep 27 2024 |
Dividend Pay Date | Dec 04 2024 |
Days until Ex dividend | 43 days |
Days until Dividend pay date | 25 days |
Does 4694 pay a reliable dividends?
See 4694 dividend history and benchmarks